Obama agency rules Pepsi use of cells derived from aborted fetus 'ordinary business'
LARGO, FL, March 5, 2012 (LifeSiteNews.com) - The Pepsi Company, which is set to release the new product Pepsi Next in the coming weeks, is facing a more robust boycott as pro-life activists protest the company use of cells derived from an aborted fetus in flavor-enhancing research. But Pepsi has succeeded, with help from the Obama Administration, in keeping its controversial operations from consideration by its shareholders.
In a decision delivered Feb 28th, President Obama’s Security and Exchange Commission (SEC) ruled that PepsiCo’s use of cells derived from aborted fetal remains in their research and development agreement with Senomyx to produce flavor enhancers falls under “ordinary business operations.”
The letter signed by Attorney Brian Pitko of the SEC Office of Chief Counsel was sent in response to a 36-page document submitted by PepsiCo attorneys in January, 2012. In that filing, PepsiCo pleaded with the SEC to reject the Shareholder’s Resolution filed in October 2011 that the company “adopt a corporate policy that recognizes human rights and employs ethical standards which do not involve using the remains of aborted human beings in both private and collaborative research and development agreements.”
Sanctity of Human Life